Scholarlink

<p>Protein tyrosine phosphatase 1B (PTP1B) is a key therapeutic target for diabetes, obesity, and cancer. However, the development of its inhibitors faces challenges including low selectivity and poor bioavailability. Although deep learning (DL) can accelerate drug discovery, prior models often overlooked structural distinctions between non-natural products (NNPs) and natural products (NPs) in chemical datasets. In this study, we separated PTP1B inhibitors and decoys into NPs and NNPs subsets to build activity prediction models tailored to their respective chemical spaces. Using transfer learning (TL), we enhanced model performance specifically for NPs. Five-fold cross-validation was used for hyperparameter optimization and for evaluating the activity prediction performance of the three model architectures. The results showed that Attentive FP (AFP) performed best among graph neural networks, Extended-Connectivity Fingerprints 4 (ECFP4) led in multi-layer perceptron (MLP) models using molecular fingerprints, and PubChem10M_SMILES_BPE_450k (P10M) excelled among SMILES-based Transformers. The new models for NPs, derived from the three model architectures via TL (pre-trained on NNPs then fine-tuned on NPs), all outperformed their original counterparts. Random splitting further confirmed the enhancing effect of TL on NPs activity prediction and the generalization ability of models. We also developed a web platform (<a href="http://ptp1bpredict.top">http://ptp1bpredict.top</a>) that allows for the independent use of the AFP, MLP-ECFP4, and P10M models, including their transfer-learned variants, to predict PTP1B inhibition by NNPs and NPs. In summary, this work provides a novel strategy for DL-based screening of PTP1B inhibitors.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A transfer learning framework for PTP1B inhibitor activity prediction: differential modeling of natural and non-natural products with web platform implementation

  • 期刊论文

  • 发表日期：

    2025年11月20日

查看全文
  • Zixiao Wang,
  • Lili Sun,
  • Anqi Ren,
  • Fang Yang,
  • Yu Chang

摘要

Protein tyrosine phosphatase 1B (PTP1B) is a key therapeutic target for diabetes, obesity, and cancer. However, the development of its inhibitors faces challenges including low selectivity and poor bioavailability. Although deep learning (DL) can accelerate drug discovery, prior models often overlooked structural distinctions between non-natural products (NNPs) and natural products (NPs) in chemical datasets. In this study, we separated PTP1B inhibitors and decoys into NPs and NNPs subsets to build activity prediction models tailored to their respective chemical spaces. Using transfer learning (TL), we enhanced model performance specifically for NPs. Five-fold cross-validation was used for hyperparameter optimization and for evaluating the activity prediction performance of the three model architectures. The results showed that Attentive FP (AFP) performed best among graph neural networks, Extended-Connectivity Fingerprints 4 (ECFP4) led in multi-layer perceptron (MLP) models using molecular fingerprints, and PubChem10M_SMILES_BPE_450k (P10M) excelled among SMILES-based Transformers. The new models for NPs, derived from the three model architectures via TL (pre-trained on NNPs then fine-tuned on NPs), all outperformed their original counterparts. Random splitting further confirmed the enhancing effect of TL on NPs activity prediction and the generalization ability of models. We also developed a web platform (http://ptp1bpredict.top) that allows for the independent use of the AFP, MLP-ECFP4, and P10M models, including their transfer-learned variants, to predict PTP1B inhibition by NNPs and NPs. In summary, this work provides a novel strategy for DL-based screening of PTP1B inhibitors.